Public Reporting A2024

ACO Name and Location:

Accountable Care Organization of Pennsylvania, LLC 
Trade Name/DBA: Delaware Valley ACO 
240 North Radnor Chester Road, Suite 270, Radnor, PA, 19087, U.S.A.

ACO Primary Contact

Mr. Robert Kagarise 
2152057264 
kagariser@dvaco.org

Organizational Information

ACO Participants:

ACO Governing Body:

Key ACO Clinical and Administrative Leadership:

ACO Executive: 
   Robert Kagarise 
Medical Director: 
   Todd Prewitt 
Compliance Officer: 
   Teresa Schorr 
Quality Assurance/Improvement Officer: 
   Lauren Talley

Associated Committees and Committee Leadership:

Types of ACO Participants, or Combinations of Participants, That Formed the ACO:

• ACO professionals in a group practice arrangement
• Partnerships or joint venture arrangements between hospitals and ACO professionals
• Hospital employing ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses:

• Fourth Agreement Period
  • Performance Year 2026, N/A
  • Performance Year 2025, N/A
  • Performance Year 2024, $49,396,726.21
  • Performance Year 2023, $32,874,619.96
• Third Agreement Period
  • Performance Year 2022, $21,781,842.00
  • Performance Year 2021, $0.00
  • Performance Year 2020, $0.00
• Second Agreement Period
  • Performance Year 2019, $0.00
  • Performance Year 2018, $0.00
  • Performance Year 2017, N/A
• First Agreement Period
  • Performance Year 2016, N/A
  • Performance Year 2015, N/A
  • Performance Year 2014, $6,567,266.87

Shared Savings Distribution:

• Fourth Agreement Period
  • Performance Year 2026
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2025
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2024
    • Proportion invested in infrastructure: 12%
    • Proportion invested in redesigned care processes/resources: 35%
    • Proportion of distribution to ACO participants: 53%
  • Performance Year 2023
    • Proportion invested in infrastructure: 23%
    • Proportion invested in redesigned care processes/resources: 27%
    • Proportion of distribution to ACO participants: 50%
• Third Agreement Period
  • Performance Year 2022
    • Proportion invested in infrastructure: 16.25%
    • Proportion invested in redesigned care processes/resources: 16.25%
    • Proportion of distribution to ACO participants: 67.5%
  • Performance Year 2021
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2020
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
• Second Agreement Period
  • Performance Year 2019
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2018
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2017
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
• First Agreement Period
  • Performance Year 2016
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2015
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2014
    • Proportion invested in infrastructure: 15%
    • Proportion invested in redesigned care processes/resources: 15%
    • Proportion of distribution to ACO participants: 70%

Quality Performance Results

2024 Quality Performance Results:

Quality performance results are based on the CMS Web Interface collection type.

For previous years’ Financial and Quality Performance Results, please visit: Data.cms.gov.

*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance. 

*For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs' providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.